Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DB58KR
|
|||
| Drug Name |
RT001
|
|||
| Indication | Friedreich's ataxia [ICD-11: 8A03.10; ICD-9: 334] | Phase 3 | [1] | |
| Iron overload disease [ICD-11: 5C64.10; ICD-10: E83.1, G23.0] | Phase 2/3 | [2] | ||
| Company |
Retrotope
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04102501) A Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects With Friedreich's Ataxia. U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT03570931) A Study to Assess Efficacy and Safety of RT001 in Subjects With Infantile Neuroaxonal Dystrophy. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.